All News

The CONVOKE study is investigating the effectiveness of the smartphone app as a therapy for negative symptoms of schizophrenia among adults.

A recent study found that reduced drug use was associated with a decrease in cravings, drug seeking behaviors, and depression severity.

According to Tyler Milliken, educating providers about prior authorization, along with other insurance processes and policies, plays a crucial role in advancing patients along their path to care.

In this conversation from the Healthcare Advocate Summit, Ned Woody, associate director of field reimbursement at Daiichi Sankyo Inc. - Oncology, discusses the disruptive impact that these programs have on patients.

Advocates can amplify the voices of transgender patients as they overcome barriers to health care, said Molly Crowther in a conversation at the 2023 Healthcare Advocate Summit.

By importing drugs in bulk from Canada, Florida aims to relieve the financial strain faced by patients who struggle to afford necessary medications.

The Starlyng-1 study showed that the treatment met its primary endpoint of a one-sided Cmin of >0.80; a one-sided Cmax of <1.25; and a two-sided Cavg of 0.80-1.40, with 90% confidence limits.

Check out our recap of last year's advancements made in the vaccine, biosimilar, and therapeutic spaces.

A Saturday Night Live skit has been met with criticism for its caricatured portrayal of patients with sickle cell disease, especially as the timing of its airing casts a dark shadow over the recent breakthrough FDA treatment approvals.

The nonprofit pharmaceutical company plans to begin fulfilling orders for RiVive more broadly in early 2023 and will make it available across the US for free of charge or at a low breakeven cost.

The federal agency also removed the maximally tolerated qualifier for statin use and the prior cardiovascular morbidity and mortality limitation of use statement.

The approvals mark a turning point in the ongoing effort to manage sickle cell disease, the most common inherited red blood cell disorder in the United States.

An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.

Levetiracetam and clobazam can cause Drug Reaction with Eosinophilia and Systemic Symptoms, which can start as a rash but progress quickly, potentially resulting in injury to internal organs, hospitalization, and death.

A study found that a pharmacist-prescribing intervention for high blood pressure could save the health care system $1.137 trillion over a 30-year period.

Providers create a disparity themselves by choosing not to treat obesity because stigma has led them to believe that patients with obesity are not sick enough to warrant medical intervention.

Newly approved by the FDA, Celltrion’s infliximab-dyyb (Zymfentra) offers patients with inflammatory bowel disease a more innovative administrative approach to infliximab treatment.

Two possibly curative gene therapies for the disease, which disproportionately affects Black people, are under consideration by the FDA.

It’s crucial to be openminded about these approaches, and to convey accurate information to patients in a nonjudgmental manner.

Digging deeper into the cause of insomnia and counseling patients on lifestyle changes can help improve their sleep health.

After several walkouts protesting poor working conditions, company executives and protest organizers came to an agreement that includes more hours for technicians and vaccinations being reduced to a manageable volume.

A new poll from the organization surveyed 10000 independent community pharmacy owners on current worries in the industry and how they are being impacted by the ongoing national drug shortage.

A study from the University of Michigan found that only 1 in 6 emergency department visits for an opioid overdose in the United States result in a prescription for buprenorphine, methadone, or extended-release naltrexone.

Pharmacists at nearly 2 dozen CVS pharmacy locations called out sick Thursday and Friday to protest recent corporate decisions they say put patients at risk of serious harm.

Your weekly roundup of the latest news from Drug Topics®.

Treatment with buprenorphine has more than doubled since 2009, but dosing guidelines are based on studies with people using heroin that were done before the fentanyl crisis.

The Ohio Board of Pharmacy found during several inspections that some CVS stores in the state had dirty conditions, a lack of control over dangerous medications, and months-long wait times for medications.